ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 78 filers reported holding ODONATE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $52,000 | -97.6% | 14,979 | -97.6% | 0.01% | -98.3% |
Q1 2021 | $2,171,000 | +135.7% | 634,728 | +1223.9% | 0.42% | +138.4% |
Q4 2020 | $921,000 | -12.4% | 47,945 | -38.8% | 0.18% | +12.7% |
Q3 2020 | $1,051,000 | -38.7% | 78,278 | +93.3% | 0.16% | -54.4% |
Q2 2020 | $1,715,000 | +26.8% | 40,500 | -17.3% | 0.34% | -38.8% |
Q1 2020 | $1,353,000 | -22.6% | 48,988 | -9.0% | 0.56% | +16.1% |
Q4 2019 | $1,747,000 | -27.7% | 53,839 | -42.0% | 0.48% | -62.8% |
Q3 2019 | $2,417,000 | -50.5% | 92,854 | -30.2% | 1.30% | -78.8% |
Q2 2019 | $4,884,000 | -5.5% | 133,105 | -43.1% | 6.14% | +147.3% |
Q1 2019 | $5,168,000 | -64.0% | 233,727 | -54.9% | 2.48% | -21.4% |
Q4 2018 | $14,355,000 | +41.2% | 518,125 | -1.1% | 3.16% | +142.7% |
Q3 2018 | $10,164,000 | -20.4% | 523,653 | -9.5% | 1.30% | -34.1% |
Q2 2018 | $12,775,000 | -58.9% | 578,599 | -60.6% | 1.97% | +6.3% |
Q1 2018 | $31,104,000 | +50.7% | 1,468,544 | +77.9% | 1.86% | -1.2% |
Q4 2017 | $20,636,000 | – | 825,451 | – | 1.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $53,060,000 | 14.93% |
SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $1,710,000 | 0.93% |
Boxer Capital, LLC | 5,607,086 | $19,176,000 | 0.65% |
Samsara BioCapital, LLC | 700,421 | $2,395,000 | 0.44% |
SABBY MANAGEMENT, LLC | 634,728 | $2,171,000 | 0.42% |
Prosight Management, LP | 117,621 | $402,000 | 0.33% |
QCM Cayman, Ltd. | 15,478 | $53,000 | 0.16% |
Ikarian Capital, LLC | 1,336,412 | $4,571,000 | 0.15% |
OCCUDO QUANTITATIVE STRATEGIES LP | 169,198 | $579,000 | 0.13% |
Walleye Capital LLC | 273,000 | $934,000 | 0.05% |